STERIS plc (STE) — Fair Value Analysis
Base-case fair value (P50): $221.74 · Current price: $218.20 · Verdict: Fairly Valued
The Verdict on STE
Steris (STE), a fixture in the Healthcare sector, appears Fairly Valued at its current market price of $218.20, according to our latest Monte Carlo simulations. The analysis indicates a median fair value (P50) of $221.74, implying a modest +1.6% against the current price. This narrow spread suggests that STE's present valuation closely aligns with its intrinsic value derived from thousands of forward-looking scenarios. Investors seeking significant short-term alpha may find the market has already largely priced in STE's current fundamentals, leaving limited immediate upside potential based on this median projection.
How STE stacks up against Healthcare
STE's operational and financial health is categorized as "average" relative to its Healthcare sector peers. This assessment aligns with the Monte Carlo verdict, which finds the stock neither significantly overvalued nor undervalued. The models account for the company's average quality tier, integrating it into the probability distributions of future cash flows and ultimately influencing the $221.74 estimate. While some sector plays might present more extreme valuation gaps, STE's current price of $218.20 reflects a market perception consistent with its qualitative standing within Healthcare.
What this means for investors
For investors, the Fairly Valued verdict on STE, with its current price of $218.20 sitting close to the $221.74 of $221.74 and a +1.6%, signals a relatively efficient market pricing. While not suggesting an immediate catalyst for outsized gains, this stability can be attractive for certain portfolio strategies. Our simulations provide a robust framework, yet the full spectrum of potential outcomes, including bear-case (P10) and bull-case (P90) scenarios, offers a more complete picture for strategic decision-making. Sign up for a free FairCurve account to see STE's full bear and bull distribution and track its fair value as new fundamentals are released.
Frequently Asked Questions
Is STE overvalued or undervalued right now?
Based on Monte Carlo simulations, Steris (STE) is currently considered Fairly Valued, with a median fair value (P50) of $221.74 closely aligning with its current price of $218.20.
What is the bear case and bull case for STE?
The full Monte Carlo distribution, including specific bear-case (P10) and bull-case (P90) price targets, as well as the probability of achieving upside, is available with a free FairCurve account.
How does FairCurve calculate STE's fair value?
FairCurve uses advanced Monte Carlo simulations to calculate STE's fair value, modeling thousands of forward-looking scenarios to arrive at a robust, probability-weighted valuation range.
How can I track STE's fair value as it changes?
You can add STE to a free FairCurve watchlist to receive daily fair-value updates and instant re-valuation whenever new earnings or fundamental data are released.